APYX Stock Analysis: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$3.67
0.11 (3.09%)
▲
5d:
+19.93%
30d:
-8.25%
90d:
-5.41%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Distribution
APYX is up 6.9% this week, but smart money is buying puts. Top strike: $2.5 2026-06-18 with 1,217 OI. Put ratio: 99% View Scanner →
Strength: 8.3/10
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APYX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $3.67, which is considered fair relative to its 30-day fair value range of $3.31 to $3.99.
Technical Outlook: Technically, APYX is showing sideways momentum. Immediate support is located at $2.76, while resistance sits at $3.83. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: APYX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.40 (+74.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APYX is showing sideways momentum. Immediate support is located at $2.76, while resistance sits at $3.83. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: APYX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.40 (+74.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.31 -
$3.99
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 74.4% below Wall St target ($6.40)
Trading Range Analysis
30-Day Trading Range
$3.31 -
$3.99
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.76
Resistance Level
$3.83
Current Trend
Sideways
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.01
Wall Street Target
$6.40
(+74.4%)
Revenue Growth (YoY)
34.7%
Profit Margin
-21.2%
Share & Embed Analysis
Last updated: May 09, 2026 4:55 AM ET
Data refreshes hourly during market hours. Next update: 5:55 AM
Data refreshes hourly during market hours. Next update: 5:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
